Thus, it is likely that, at least from the point of view of atherosclerosis, lipid-poor apoA-I is oxidized by macrophage derived myeloperoxidase in the artery wall resulting in impaired reverse cholesterol transport. Here, APOA1 is linked to atherosclerosis.